IP Library Granted Patent US 11,802,882
Granted Patent B2
US 11,802,882 · App. 16/222,845 · Granted Oct 31, 2023

Methods for the detection of analytes in small-volume blood samples

Inventors: Ian Gibbons (Newark, CA); Shaunak Roy (Palo Alto, CA); Edmond Ku (Palo Alto, CA)
Assignee: Labrador Diagnostics LLC
G01N33/92B01L3/502707B01L3/502715B01L3/502753C12Q1/60G01N21/27G01N21/31G01N33/525G01N33/5302B01L2200/0605B01L2200/0631B01L2200/10B01L2300/0654B01L2300/087B01L2300/0819B01L2300/0874B01L2300/0887B01L2300/168G01N2201/061G01N2201/062Y10T436/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,802,882
App. No.
16/222,845
Granted
Oct 31, 2023
Kind
B2
Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

Claims (30)

1. A microfluidic cartridge for carrying out an assay to detect an analyte in a bodily fluid sample, comprising:

a sample collection unit comprising a sample collection well for receiving the bodily fluid sample;

an assay unit in fluid communication with the sample collection well, wherein the assay unit comprises a reactant chamber having a reaction site with a reactant immobilized on the reaction site and configured to react with the analyte in the bodily fluid sample to generate a colored product having an absorbance spectrum; and

a light source comprising a luminescent paint coated on the reaction site, wherein a spectrum of light emitted from the luminescent paint has at least one wavelength that is a function of the absorbance spectrum.

2. The microfluidic cartridge of claim 1 , wherein the sample collection unit further comprises a metering channel in fluid communication with the sample collection well, the metering channel configured to collect a predetermined portion of the bodily fluid sample to be assayed, wherein the assay unit is in fluid communication with the sample collection well by means of the metering channel, and wherein the predetermined portion of the bodily fluid sample has a volume of about 10 to about 50 microliters.

3. The microfluidic cartridge of claim 2 , wherein the metering channel comprises a metering element configured to close off fluidic connection between the sample collection well and the metering channel to prevent a volume of the bodily fluid sample larger than the predetermined portion of the bodily fluid sample from being assayed.

4. The microfluidic cartridge of claim 3 , wherein the metering element is a pin that is movable so as to close off fluidic connection between the sample collection well and the metering channel.

5. The microfluidic cartridge of claim 1 , wherein the reactant chamber comprises a cylindrical configuration.

6. The microfluidic cartridge of claim 1 , wherein the reactant chamber is at least partially transparent such that light can be transmitted through the reactant chamber.

7. The microfluidic cartridge of claim 6 , wherein the reactant chamber comprises functionalized glass.

8. The microfluidic cartridge of claim 2 , further comprising a dilution chamber in fluid communication with the metering channel of the sample collection unit, wherein the dilution chamber is configured to store a diluent.

9. The microfluidic cartridge of claim 1 , further comprising a reagent chamber for storing a reagent for carrying out the assay to detect the analyte, wherein the reagent chamber is in fluid communication with the reactant chamber of the assay unit.

10. The microfluidic cartridge of claim 9 , wherein the reagent chamber stores a reagent selected from a wash buffer, an enzyme substrate, a dilution buffer, a conjugate, an enzyme-labeled conjugate, a DNA amplifier, a sample diluent, a wash solution, a detergent, a polymer, a chelating agent, an albumin-binding reagent, an enzyme inhibitor, an enzyme, an anticoagulant, a red-cell agglutinating agent, and an antibody.

11. The microfluidic cartridge of claim 1 , wherein the microfluidic cartridge comprises all reagents necessary to perform the assay to detect the analyte.

12. The microfluidic cartridge of claim 1 , wherein the microfluidic cartridge comprises a length of about 7 cm to about 30 cm, and a width of about 5 cm to about 30 cm.

13. The microfluidic cartridge of claim 1 , further comprising a plurality of reactant chambers of a plurality of assay units, and wherein each reactant chamber of the plurality of reactant chambers comprises a reaction site with a different reactant immobilized on the reaction site for reacting with a different analyte in the bodily fluid sample.

14. A point-of-care system for detecting an analyte in a bodily fluid sample, comprising:

a microfluidic cartridge, comprising:

a sample collection unit comprising a sample collection well for receiving the bodily fluid sample,

an assay unit in fluid communication with the sample collection well, wherein the assay unit comprises a reactant chamber having a reaction site with a reactant immobilized on the reaction site and configured to react with the analyte in the bodily fluid sample to generate a colored product having an absorbance spectrum, and

a light source comprising a luminescent paint coated on the reaction site, wherein a spectrum of light emitted from the luminescent paint has at least one wavelength that is a function of the absorbance spectrum; and

a bench-top reader assembly configured to receive the microfluidic cartridge, wherein the bench-top reader assembly comprises:

one or more actuating elements that direct and control a flow of the bodily fluid sample from the sample collection unit to the assay unit of the microfluidic cartridge, and

a detector configured to detect an absorption of light of the at least one wavelength, wherein the absorption of light is indicative of the presence of the analyte.

15. The point-of-care system of claim 14 , wherein the reader assembly further comprises a controller configured to control the one or more actuating elements according to a protocol for conducting the assay to detect the analyte.

16. The point-of-care system of claim 15 , wherein the reader assembly further comprises a communication assembly for transmitting a signal detected by the detector to an external device for processing.

17. The point-of-care system of claim 14 , wherein the detector is an optical detector.

18. The point-of-care system of claim 14 , wherein the microfluidic cartridge further comprises a waste chamber in fluid communication with the reactant chamber, and wherein the reader assembly is further configured to direct flow of the bodily fluid sample from the reactant chamber to the waste chamber.

19. The point-of-care system of claim 14 , wherein the microfluidic cartridge further comprises a reagent chamber that stores a reagent for conducting the assay to detect the analyte, and

wherein the reader assembly is configured to direct flow of the reagent from the reagent chamber to the reactant chamber.

Assignments (1)
CHANGE OF NAME Recorded Apr 7, 2020
From: THERANOS IP COMPANY LLC
To: LABRADOR DIAGNOSTICS LLC
Reel/Frame 052329/0716 →
Continuity (6)
Continuation 15054510 · Feb 26, 2016
Continuation 14285562 · May 22, 2014
Division 12750518 · Mar 30, 2010
Continuation 11939509 · Nov 13, 2007
Provisional Application 60865805 · Nov 14, 2006
Related Publication 20190128902A1 · May 2, 2019